| Literature DB >> 26154780 |
Stine C Klinger1, Piotr Siupka2, Morten S Nielsen2.
Abstract
Transport between the endoplasmatic reticulum, the Golgi-network, the endo-lysosomal system and the cell surface can be categorized as anterograde or retrograde, describing traffic that goes forward or backward, respectively. Traffic going from the plasma membrane to endosomes and lysosomes or the trans-Golgi network (TGN) constitutes the major retrograde transport routes. Several transmembrane proteins undergo retrograde transport as part of a recycling mechanism that contributes to reutilization and maintenance of a steady-state protein localization. In addition, some receptors are hijacked by exotoxins and used for entry and intracellular transport. The physiological relevance of retrograde transport cannot be overstated. Retrograde trafficking of the amyloid precursor protein determines the distribution between organelles, and hence the possibility of cleavage by γ-secretase. Right balancing of the pathways is critical for protection against Alzheimer's disease. During embryonic development, retrograde transport of Wntless to the TGN is essential for the following release of Wnt from the plasma membrane. Furthermore, overexpression of Wntless has been linked to oncogenesis. Here, we review relevant aspects of the retrograde trafficking of mammalian transmembrane receptors and transporters, with focus on the retromer-mediated transport between endosomes and the TGN.Entities:
Keywords: MPRs; TGN; endosomes; receptor; retrograde; retromer; sortilins; trafficking; transmembrane; transporter
Year: 2015 PMID: 26154780 PMCID: PMC4584283 DOI: 10.3390/membranes5030288
Source DB: PubMed Journal: Membranes (Basel) ISSN: 2077-0375
Figure 1Retrograde trafficking of receptors. Retrograde trafficking can be divided into routes going from early endosomes towards the trans-Golgi network (TGN), from late endosomes or via recycling endosomes. The most common route goes from early endosomes and is mediated by the SNX-BAR-retromer as well as the SNX3-retromer. The SNX-BAR-retromer mediates trafficking of MPR300 and the sortilin family members via the tubular-endosomal network (route 1), while the SNX3-retromer mediates trafficking of Wntless (route 2). The route from late endosomes is mainly used by MPR300 independent of retromer (route 3). Abbreviations: PM: plasma membrane; ER: endoplasmatic reticulum; RE: recycling endosome; EE: early endosome; LE: late endosome; TEN: tubular-endosomal network.
Figure 2Retromer interactions with type-1 receptors. The retromer core complex consists of Vps35, Vps26 and Vps29. The banana-shaped Vps35 interacts with Vps26 through its N-terminal and Vps29 through the C-terminal. Located at endosomes, type-1 receptors have been reported to bind to Vps35 as well as Vps26. MPR300, sortilin and SorCS-1C bind Vps35; MPR300 via a WLM motif while the binding motifs in sortilin and SorCS-1C are unknown. Sortilin may also interact with Vps26, whereas SorLA has only been reported to bind Vps26 through a FANSHY motif.
Receptors and transporters engaging in retromer-mediated traffic.
| Receptors | Type | Ligands | Retromer sorting | Interacting retromer subunit | Receptor binding motif | References |
|---|---|---|---|---|---|---|
| CI-MPR (MPR300) | Type-I | M6P containing ligands: acidic hydrolases, TGF-β1, proliferin, granzyme B, thyroglobulin; Non-M6P containing ligands: IGF-II, retinoic acid, uPAR, plasminogen, serglycin | EE to TGN | Vps35 | WLM | 26 |
| SorLA (LR11) | Type-I | LpL, apoE, apoA-V-DMPC, GDNF, GFRα1, uPA-PAI1 | EE to TGN | Vps26 | FANSHY | 30, 107 |
| Sortilin | Type-I | LpL, pro-NGF, neurotensin, progranulin PGRN, IL6, | EE to TGN | Vps35 |
| 29,105 |
| SorCS-1 | Type-I | PDGF-BB, APP, sortilin |
| Vps35 |
| 108,109 |
| pIgR | Type-I | IgA | Transcytosis | Vps35 |
| 65 |
| Wntless (GPR177) | 7TM | Wtn family proteins | EE to TGN | Vps35 | FLM | 120, 124 |
|
|
| |||||
| Menkes protein (ATP7A) | ATPase (8TM) | Cu++ | Recycling to cell surface | Vps26 |
| 45, 132 |
| Glut4 | 12 TM | Glucose | EE to TGN |
|
| 128, 130 |
| DMT1-II | 12 TM | Divalent cation transporter | Recycling to cell surface |
| YLL | 135, 136 |